{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T18:52:23Z","timestamp":1751395943618,"version":"3.37.3"},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Institutes of Health\u2019s National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002494"],"award-info":[{"award-number":["UL1TR002494"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,24]]},"abstract":"<jats:p>Current validated hidradenitis suppurativa (HS) severity assessment tools are time-consuming and impractical in fast-paced, ambulatory clinic settings. This study evaluated the construct validity of the most severe or \u2018worst\u2019 area local Hidradenitis suppurativa Activity and Severity Index-Revised (W-HASI-R) as a novel target area assessment tool for clinical setting use. W-HASI-R had strong association with the International Hidradenitis Suppurativa Severity Score System and abscess and nodule count, moderate association with Hurley stage and HS physician global assessment and weak, negative association with reverse-scored Dermatology Quality Life Index. The resulting data suggest that W-HASI-R may be an option as an efficient target area assessment tool for fast-paced, ambulatory settings.<\/jats:p>","DOI":"10.1093\/bjd\/ljad138","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T05:56:33Z","timestamp":1683266193000},"page":"338-354","source":"Crossref","is-referenced-by-count":1,"title":["Worst area local Hidradenitis suppurativa Activity and Severity Index-Revised (W-HASI-R): a study evaluating construct validity"],"prefix":"10.1093","volume":"189","author":[{"given":"Gretchen","family":"Bellefeuille","sequence":"first","affiliation":[{"name":"Departments of Dermatology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Briana","family":"Paiewonsky","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and"},{"name":"Charles E. Schmidt College of Medicine, Florida Atlantic University , Boca Raton, FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bisma","family":"Khalid","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca L","family":"Freese","sequence":"additional","affiliation":[{"name":"Biostatistical Design and Analysis Center, Clinical and Translational Science Institute, University of Minnesota , Minneapolis, MN , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle\u00a0A","family":"Lowes","sequence":"additional","affiliation":[{"name":"The Rockefeller University , New York, NY , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joslyn S","family":"Kirby","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Penn State Health Milton S. Hershey Medical Center , Hershey, PA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afsaneh","family":"Alavi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mayo Clinic , Rochester, MN , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1070-0652","authenticated-orcid":false,"given":"Noah","family":"Goldfarb","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and"},{"name":"Medicine, University of Minnesota Academic Health Center , Minneapolis, MN , USA"},{"name":"Departments of Medicine and Dermatology, Minneapolis Veterans Affairs Health Care System , Minneapolis, MN , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"2023100916000008500_ljad138-B1","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/bjd.16672","article-title":"A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process","volume":"179","author":"Thorlacius","year":"2018","journal-title":"Br J Dermatol"},{"key":"2023100916000008500_ljad138-B2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/jdv.13216","article-title":"HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study","volume":"30","author":"Kimball","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023100916000008500_ljad138-B3","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/bjd.15748","article-title":"Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity","volume":"177","author":"Zouboulis","year":"2017","journal-title":"Br J Dermatol"},{"key":"2023100916000008500_ljad138-B4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/bjd.19565","article-title":"Hidradenitis Suppurativa Area and Severity Index Revised (HASI-R): psychometric property assessment","volume":"184","author":"Goldfarb","year":"2021","journal-title":"Br J Dermatol"},{"key":"2023100916000008500_ljad138-B5","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/bjd.18244","article-title":"Severity and Area Score for Hidradenitis (SASH): a novel outcome measurement for hidradenitis suppurativa","volume":"182","author":"Kirby","year":"2020","journal-title":"Br J Dermatol"},{"key":"2023100916000008500_ljad138-B6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/bjd.18436","article-title":"Putting nodule counts behind us: hidradenitis suppurativa outcome measures independent of descriptive semantics","volume":"182","author":"Frew","year":"2020","journal-title":"Br J Dermatol"},{"issue":"5 Suppl. 1","key":"2023100916000008500_ljad138-B7","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jaad.2015.07.047","article-title":"New insights into the diagnosis of hidradenitis suppurativa: clinical presentations and phenotypes","volume":"73","author":"Van der Zee","year":"2015","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljad138\/50689833\/ljad138.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/189\/3\/338\/51960584\/ljad138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/189\/3\/338\/51960584\/ljad138.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T16:00:52Z","timestamp":1696867252000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/189\/3\/338\/7152693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":7,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,5,5]]},"published-print":{"date-parts":[[2023,8,24]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljad138","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"type":"print","value":"0007-0963"},{"type":"electronic","value":"1365-2133"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,5,5]]}}}